The lack of a Sirt1 KO effect in aging females was not due to the slower disease kinetics because increasing female BM cell transduction rates to accelerate CML development still failed to distinguish Sirt1+/+ and Sirt1-/- CML development (Fig. 8e). This evidence concerns the gene SIRT1 and chronic myelogenous leukemia, BCR-ABL1 positive.